Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis

被引：31
|
作者：
Manosuthi, Weerawat
Ruxrungtham, Kiat
Likanonsakul, Sirirat
Prasithsirikul, Wisit
Inthong, Yaowarat
Phoorisri, Thanongsri
Sungkanuparph, Somnuek
机构：
[1] Bamrasnaradura Infect Dis Inst, Minist Publ Hlth, Dept Med, Nonthaburi 11000, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand
[3] Chulalongkorn Univ, Bangkok, Thailand
[4] Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand
来源：
CLINICAL INFECTIOUS DISEASES | 2007年 / 44卷 / 01期
关键词：
D O I：
10.1086/510078
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Seventy patients with human immunodeficiency virus (HIV) and tuberculosis coinfection who initiated nevirapine-based antiretroviral therapy and had trough nevirapine levels determined while receiving rifampicin were enrolled in a study. After discontinuation of rifampicin therapy, mean nevirapine levels (+/- standard deviation) increased from 5.4 +/- 3.5mg/L to 6.4 +/- 3.4mg/ L (P = .047), but no nevirapine-related adverse events occurred. There was no statistically significant difference in 60-week antiviral efficacy between these patients and patients receiving nevirapine-based antiretroviral therapy alone (P >.05).
引用
收藏
页码：141 / 144
页数：4
相关论文
共 50 条
  • [1] Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin
    Manosuthi, Weerawat
    Sungkanuparph, Somnuek
    Thakkinstian, Ammarin
    Rattanasiri, Sasivimol
    Chaovavanich, Achara
    Prasithsirikul, Wisit
    Likanonsakul, Sirirat
    Ruxrungtham, Kiat
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (02) : 253 - 255
  • [2] Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
    Manosuthi, Weerawat
    Athichathanabadi, Chatiya
    Uttayamakul, Sumonmal
    Phoorisri, Thanongsri
    Sungkanuparph, Somnuek
    [J]. BMC INFECTIOUS DISEASES, 2007, 7 (1)
  • [3] Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
    Weerawat Manosuthi
    Chatiya Athichathanabadi
    Sumonmal Uttayamakul
    Thanongsri Phoorisri
    Somnuek Sungkanuparph
    [J]. BMC Infectious Diseases, 7
  • [4] Discontinuation Rate of Nevirapine-Based Highly Active Antiretroviral Therapy
    Gorgolas, Miguel
    Hidalgo, Cristina
    Williams, Frances
    Fernandez Guerrero, Manuel
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (01) : 82 - 82
  • [5] Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy
    Arpadi, Stephen
    Shiau, Stephanie
    Strehlau, Renate
    Martens, Leigh
    Patel, Faeezah
    Coovadia, Ashraf
    Abrams, Elaine J.
    Kuhn, Louise
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2013, 98 (04) : 258 - 264
  • [6] Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults
    Fehintola, Fatai A.
    Scarsi, Kimberly K.
    Ma, Qing
    Parikh, Sunil
    Morse, Gene D.
    Taiwo, Babafemi
    Akinola, Ibrahim Tope
    Adewole, Isaac F.
    Lindegardh, Niklas
    Phakderaj, Aphiradee
    Ojengbede, Oladosu
    Murphy, Robert L.
    Akinyinka, Olusegun O.
    Aweeka, Francesca T.
    [J]. AIDS RESEARCH AND TREATMENT, 2012, 2012
  • [7] Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapy
    Padmapriyadarsini, C.
    Ramesh, K.
    Sekar, L.
    Reddy, Devaraj
    Narendran, G.
    Sekar, S.
    Chandrasekar, C.
    Anbarasu, D.
    Wanke, Christine
    Swaminathan, Soumya
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 145 : 640 - 649
  • [8] Combined antiretroviral therapy with nevirapine of HIV-infected adults
    Kravchenko, AV
    [J]. TERAPEVTICHESKII ARKHIV, 2004, 76 (11): : 68 - 71
  • [9] Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis
    Ribera, E
    Pou, L
    Lopez, RM
    Crespo, M
    Falco, V
    Ocaña, I
    Ruiz, I
    Pahissa, A
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 28 (05): : 450 - 453
  • [10] Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon
    Jules B Tchatchueng Mbougua
    Christian Laurent
    Charles Kouanfack
    Anke Bourgeois
    Laura Ciaffi
    Alexandra Calmy
    Henri Gwet
    Sinata Koulla-Shiro
    Jacques Ducos
    Eitel Mpoudi-Ngolé
    Nicolas Molinari
    Eric Delaporte
    [J]. BMC Public Health, 10
12345